Conceptus, Inc. Reports Second Quarter Sales of $36.8 Million

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Conceptus, Inc. (Nasdaq:CPTS), developer of the Essure(R) procedure, the first proven non-surgical permanent birth control method available, today reported financial results for the three months ended June 30, 2010.
MORE ON THIS TOPIC